Hereditary Angioedema: Molecular Mechanisms and Clinical Management leaf node


URI

https://openalex.org/T11917

Label

Hereditary Angioedema: Molecular Mechanisms and Clinical Management

Description

This cluster of papers focuses on the molecular mechanisms, pathophysiological consequences, and clinical management of Hereditary Angioedema. It covers topics such as the role of kinin receptors, coagulation factors XII and XI, polyphosphate, C1 inhibitor deficiency, and the use of bradykinin-receptor antagonists in the treatment of angioedema. Additionally, it explores the involvement of tissue kallikreins and the contact activation system in the disease pathology.

Implementation

@prefix oasubfields: <https://openalex.org/subfields/> .
@prefix openalex: <https://lambdamusic.github.io/openalex-hacks/ontology/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://openalex.org/T11917> a skos:Concept ;
    rdfs:label "Hereditary Angioedema: Molecular Mechanisms and Clinical Management"@en ;
    rdfs:isDefinedBy openalex: ;
    owl:sameAs <https://en.wikipedia.org/wiki/Hereditary_angioedema>,
        <https://openalex.org/T11917> ;
    skos:broader oasubfields:2716 ;
    skos:definition "This cluster of papers focuses on the molecular mechanisms, pathophysiological consequences, and clinical management of Hereditary Angioedema. It covers topics such as the role of kinin receptors, coagulation factors XII and XI, polyphosphate, C1 inhibitor deficiency, and the use of bradykinin-receptor antagonists in the treatment of angioedema. Additionally, it explores the involvement of tissue kallikreins and the contact activation system in the disease pathology."@en ;
    skos:inScheme openalex: ;
    skos:prefLabel "Hereditary Angioedema: Molecular Mechanisms and Clinical Management"@en ;
    openalex:cited_by_count 719963 ;
    openalex:works_count 39932 .